Concepedia

Author

William Pierce

University of California, Los Angeles

Also Known As

W C Pierce, W. Pierce, W.C. Pierce, William C. Pierce, William Pierce

21

Publications

698

Citations

12

H-Index

20

Concepts

All Affiliations

University of California, Los AngelesComprehensive Cardiovascular
WP

About

William Pierce is an author at University of California, Los Angeles specializing in medicine, urology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

348

2

Immunology

3

3

47

3

Molecular Biology

1

1

44

4

Nephrology

1

1

12

5

Surgical Oncology

1

1

12

William Pierce

×

12

Publications

636

Citations

12

H-Index

YearCitations

Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer

Tomasz M. Beer, William Pierce, B A Lowe,

Annals of Oncology

2001

192

Treatment of Metastatic Renal Cell Carcinoma With Nephrectomy, Interleukin-2 and Cytokine-Primed or CD8(+) Selected Tumor Infiltrating Lymphocytes from Primary Tumor

Robert A. Figlin, William Pierce, Randir Kaboo,

The Journal of Urology

1997

160

Interferon-<i>α</i>Primed Tumor-Infiltrating Lymphocytes Combined with Interleukin-2 and Interferon-<i>α</i>as Therapy for Metastatic Renal Cell Carcinoma

Arie S. Belldegrun, William Pierce, Randhir Kaboo,

The Journal of Urology

1993

73

Molecular biology of adenovirus type 2 semipermissive infections I. Viral growth and expression of viral replicative functions during restricted adenovirus infection

Faye A. Eggerding, William Pierce

Virology

1986

44

Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.

William Pierce, Arie S. Belldegrun, Robert A. Figlin

PubMed

1995

32

Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors

John E. Janik, William H. Sharfman, John W. Smitht,

Cancer

1993

31

Natural Immune Reactivity-Associated Therapeutic Response in Patients with Metastatic Renal Cell Carcinoma Receiving Tumor-Infiltrating Lymphocytes and Interleukin-2-Based Therapy

Arie S. Belldegrun, Cho-Lea Tso, Randhir Kaboo,

Journal of Immunotherapy

1996

24

MANAGEMENT OF DISSEMINATED KIDNEY CANCER

Samir S. Taneja, William Pierce, Robert A. Figlin,

Urologic Clinics of North America

1994

21

Patterns of Cytokine Release of Unselected and CD8+ Selected Renal Cell Carcinoma Tumor-Infiltrating Lymphocytes (TIL)

Günther Steger, William Pierce, Robert A. Figlin,

Clinical Immunology and Immunopathology

1994

20

Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.

Robert A. Figlin, William Pierce, A Belldegrun

PubMed

1993

15

Page 1